PGP and breast cancer: The possible increased LAK susceptibility and binding of P-gp(+) MDR metastatic breast cancer cells as suggested in this paper encourages studies toward mAbs and LAK cells for the treatment of breast cancer patients since LAK cells have strong ADCC.